Literature DB >> 25071870

The role of antiproliferative gene Tob1 in the immune system.

Sergio E Baranzini1.   

Abstract

Tob1 (transducer of ERBB2-1, TOB1 is humans) is a member of the antiproliferative (APRO) family of proteins that controls cell cycle progression in several cell types. In addition, Tob1 has been implicated in diverse cellular mechanisms such as embryonic dorsal development, and T helper 17 (Th17) cell function. More recently, evidence linking Tob1 function to experimental and human immune related disorders has mounted, thus underscoring the potential of this molecule as a biomarker and as a therapeutic target. This article reviews these functions with an emphasis on their implications for human autoimmune diseases such as multiple sclerosis.

Entities:  

Keywords:  Biomarker; T lymphocyte.; cell proliferation; multiple sclerosis; quiescence

Year:  2014        PMID: 25071870      PMCID: PMC4111268          DOI: 10.1111/cen3.12125

Source DB:  PubMed          Journal:  Clin Exp Neuroimmunol        ISSN: 1759-1961


  29 in total

1.  The negative cell cycle regulator, Tob (transducer of ErbB-2), is a multifunctional protein involved in hippocampus-dependent learning and memory.

Authors:  M Jin; X-M Wang; Y Tu; X-H Zhang; X Gao; N Guo; Z Xie; G Zhao; N Jing; B-M Li; L Yu
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

2.  A P-insertion screen identifying novel X-linked essential genes in Drosophila.

Authors:  Henri-Marc Bourbon; Geneviève Gonzy-Treboul; Frédérique Peronnet; Marie-Francoise Alin; Claude Ardourel; Corinne Benassayag; David Cribbs; Jean Deutsch; Pierre Ferrer; Marc Haenlin; Jean-Antoine Lepesant; Stéphane Noselli; Alain Vincent
Journal:  Mech Dev       Date:  2002-01       Impact factor: 1.882

3.  Cloning and characterization of the mouse tob gene.

Authors:  Y Yoshida; S Matsuda; T Yamamoto
Journal:  Gene       Date:  1997-05-20       Impact factor: 3.688

4.  Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells.

Authors:  D Tzachanis; G J Freeman; N Hirano; A A van Puijenbroek; M W Delfs; A Berezovskaya; L M Nadler; V A Boussiotis
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

5.  Interaction of anti-proliferative protein Tob with poly(A)-binding protein and inducible poly(A)-binding protein: implication of Tob in translational control.

Authors:  Kentaro Okochi; Toru Suzuki; Jun-ichiro Inoue; Satoru Matsuda; Tadashi Yamamoto
Journal:  Genes Cells       Date:  2005-02       Impact factor: 1.891

Review 6.  Tob genes in development and homeostasis.

Authors:  Shunji Jia; Anming Meng
Journal:  Dev Dyn       Date:  2007-04       Impact factor: 3.780

7.  Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases.

Authors:  N Ikematsu; Y Yoshida; J Kawamura-Tsuzuku; M Ohsugi; M Onda; M Hirai; J Fujimoto; T Yamamoto
Journal:  Oncogene       Date:  1999-12-09       Impact factor: 9.867

8.  Human carbon catabolite repressor protein (CCR4)-associative factor 1: cloning, expression and characterization of its interaction with the B-cell translocation protein BTG1.

Authors:  J A Bogdan; C Adams-Burton; D L Pedicord; D A Sukovich; P A Benfield; M H Corjay; J K Stoltenborg; I B Dicker
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

9.  Tob proteins enhance inhibitory Smad-receptor interactions to repress BMP signaling.

Authors:  Yutaka Yoshida; Andreas von Bubnoff; Naoko Ikematsu; Ira L Blitz; Junko K Tsuzuku; Eri H Yoshida; Hisashi Umemori; Kohei Miyazono; Tadashi Yamamoto; Ken W Y Cho
Journal:  Mech Dev       Date:  2003-05       Impact factor: 1.882

10.  Human TOB, an antiproliferative transcription factor, is a poly(A)-binding protein-dependent positive regulator of cytoplasmic mRNA deadenylation.

Authors:  Nader Ezzeddine; Tsung-Cheng Chang; Wenmiao Zhu; Akio Yamashita; Chyi-Ying A Chen; Zhenping Zhong; Yukiko Yamashita; Dinghai Zheng; Ann-Bin Shyu
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

View more
  7 in total

Review 1.  Rethinking peripheral T cell tolerance: checkpoints across a T cell's journey.

Authors:  Mohamed A ElTanbouly; Randolph J Noelle
Journal:  Nat Rev Immunol       Date:  2020-10-19       Impact factor: 53.106

2.  The Putative Association of TOB1-AS1 Long Non-coding RNA with Immune Tolerance: A Study on Multiple Sclerosis Patients.

Authors:  Reyhaneh Dehghanzad; Majid Pahlevan Kakhki; Asieh Alikhah; Mohammad Ali Sahraian; Mehrdad Behmanesh
Journal:  Neuromolecular Med       Date:  2019-09-03       Impact factor: 3.843

3.  Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis.

Authors:  Kicheol Kim; Anne-Katrin Pröbstel; Ryan Baumann; Julia Dyckow; James Landefeld; Elva Kogl; Lohith Madireddy; Rita Loudermilk; Erica L Eggers; Sneha Singh; Stacy J Caillier; Stephen L Hauser; Bruce A C Cree; Lucas Schirmer; Michael R Wilson; Sergio E Baranzini
Journal:  Brain       Date:  2021-03-03       Impact factor: 13.501

4.  Antigen presentation between T cells drives Th17 polarization under conditions of limiting antigen.

Authors:  Viola L Boccasavia; Elena R Bovolenta; Ana Villanueva; Aldo Borroto; Clara L Oeste; Hisse M van Santen; Cristina Prieto; Diego Alonso-López; Manuel D Diaz-Muñoz; Facundo D Batista; Balbino Alarcón
Journal:  Cell Rep       Date:  2021-03-16       Impact factor: 9.995

5.  Increased expression of Tbet in CD4(+) T cells from clinically isolated syndrome patients at high risk of conversion to clinically definite MS.

Authors:  Christopher McGuigan; Jean M Fletcher; Sharee A Basdeo; Siobhan Kelly; Karen O'Connell; Niall Tubridy
Journal:  Springerplus       Date:  2016-06-18

6.  Association between the SNPs of the TOB1 gene and gastric cancer risk in the Chinese Han population of northeast China.

Authors:  Hui Wang; Huiting Hao; Haonan Guo; Yuanyuan Wang; Xuelong Zhang; Lidan Xu; Jingcui Yu
Journal:  J Cancer       Date:  2018-04-06       Impact factor: 4.207

7.  VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance.

Authors:  Mohamed A ElTanbouly; Yanding Zhao; Elizabeth Nowak; Jiannan Li; Evelien Schaafsma; Isabelle Le Mercier; Sabrina Ceeraz; J Louise Lines; Changwei Peng; Catherine Carriere; Xin Huang; Maria Day; Brent Koehn; Sam W Lee; Milagros Silva Morales; Kristin A Hogquist; Stephen C Jameson; Daniel Mueller; Jay Rothstein; Bruce R Blazar; Chao Cheng; Randolph J Noelle
Journal:  Science       Date:  2020-01-17       Impact factor: 63.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.